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Abstract
Objective—To define the pattern of dis-
ease expression in patients with childhood
onset systemic lupus erythematosus
(SLE).
Methods—Prospective analysis of clinical
manifestations and immunological fea-
tures of 34 patients in whom the first
manifestations appeared in childhood
from a series of 430 unselected patients
with SLE.
Results—Thirty one (91%) patients from
the childhood onset group were female
and three male (9%) (ratio female/male,
10/1, with no diVerence compared with the
adult onset group).Mean age of this group
at disease onset was 11 years (range 5–14)
compared with 32 years (15–48) for the
remaining patients. The childhood onset
patients more often had nephropathy
(20% v 9% in adult onset SLE, p=0.04;
OR:2.7; 95%CI:1.1, 7), fever (41% v 21%,
p=0.006; OR:2.6, 95%CI:1.2, 5.7), and
lymphadenopathy (6% v 0.5%, p=0.03,
OR: 12.3, 95%CI: 1.2, 127.6), as presenting
clinical manifestations. During the evolu-
tion of the disease, the childhood onset
patients had an increased prevalence of
malar rash (79% v 51%, p=0.002; OR:3.7;
95%CI:1.5, 9.5) and chorea (9% v 0%,
p<0.0001). This group exhibited a higher
prevalence of anticardiolipin antibodies
(aCL) of the IgG isotype when compared
with the remaining patients (29% v 13%,
p=0.017; OR:2.9, 95%CI:1.2, 6.8). No sig-
nificant diVerences were found among the
other antibodies between the two groups.
Childhood onset patients more often re-
ceived azathioprine (15% v 6%, p=0.00004;
OR:11.2; 95%CI:2.8, 44.9) but no diVer-
ences were detected between the groups
concerning side eVects or drug toxicity.
Conclusions—The presentation and the
clinical course of SLE varied in this series
of 430 patients depending on their age at
disease onset. Nephropathy, fever, and
lymphadenopathy were more common in
childhood onset patients as presenting
clinical manifestations, while malar rash,
chorea, and detection of IgG aCL were
more common during the evolution of the
disease.
(Ann Rheum Dis 1998;57:456–459)
Systemic lupus erythematosus (SLE) predomi-
nantly aVects young women in reproductive
age.1 In 10–20% of patients, however, the diag-
nosis is made for the first time in childhood.2–6
Several investigators have reported that age
at onset has a modifying eVect on disease
expression. This is important because exami-
nation of more homogeneous subsets, such as
childhood onset patients, may allow for earlier
diagnosis, better treatment, and more accurate
prognosis. It has been noted that certain
features of SLE usually associated with sever-
ity, such as nephritis or central nervous system
dysfunction, are more common in patients with
childhood onset SLE. In addition, serological
abnormalities have also been reported to be
diVerent in childhood patients.2–6 However, the
small number of patients that have been
analysed in the diVerent series, the disparity in
selection criteria for patient inclusion, the age
limits adopted, or the definition of the variables
make comparison of findings in previous
reports very diYcult.
In this study, to better define the pattern of
disease expression in childhood onset SLE
patients, we have prospectively analysed the
clinical manifestations and immunological fea-
tures of 34 patients in whom the first manifes-
tations appeared in the childhood from a series
of 430 unselected patients with SLE.
Methods
PATIENT SELECTION
We studied prospectively 430 patients with
SLE who were seen consecutively either as
inpatients or outpatients between 1980 and
1995 and who were followed up by the same
attending physicians (JF, RC, LP,MI). All were
white and met the American College of Rheu-
matology (formerly American Rheumatism
Association, ARA)7 revised criteria for SLE. In
34 (8%) the onset of disease, defined as the
initial manifestation clearly attributable to
SLE, occurred before the age of 14, and they
represent the childhood onset group described
in this report. The remaining 396 (92%)
patients presented the initial manifestations
after the age of 14, and they represent the adult
onset group. All had medical histories docu-
mented and underwent medical interview as
well as routine general physical examination by
a qualified internist. A serum sample from each
patient was collected for the immunological
tests. Clinical and serological characteristics of
all these patients were collected in a protocol
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form. Salient features included in this protocol
were: (1) age at onset of the disease, (2) age at
diagnosis, defined as the age when the patient
fulfilled four or more of the 1982 revised ARA
criteria for the classification of SLE, (3) time of
evolution of the disease, defined as the time
from the onset until the present study, (4)
clinical manifestations at the onset, (5) cumu-
lative clinical manifestations during the evolu-
tion of the disease, and (6) laboratory features
at diagnosis. Information collected into the
protocol forms was transferred to a computer-
ised database program (DBASE IV).
DEFINITION OF CLINICAL FEATURES
To minimise possible inter-observer bias, the
variables of this protocol were carefully dis-
cussed by all the participating physicians on
several occasions. The clinical manifestations
evaluated in this protocol were defined accord-
ing to the ARA glossary committee.8
LABORATORY STUDIES
Antinuclear antibodies (ANA) were deter-
mined by indirect immunofluorescence using
mouse liver as substrate and regarded as
positive if higher than 1:100. Anti-dsDNA
antibodies were determined with Farr’s ammo-
nium sulphate precipitation technique and
considered as positive if higher than 7 U/ml.
Precipitating antibodies to extractable nuclear
antigens (ENA), including Ro(SSA), La(SSB),
U1-snRNP and Sm were detected by counter-
immunoelectrophoresis using calf and rabbit
thymus and human spleen extracts. Rheuma-
toid factor (RF) was detected by latex test and
regarded as positive if higher than 25 UI/ml.
Anticardiolipin antibodies (aCL) of the IgG
and IgM isotypes were measured by an ELISA
method as described by Gharavi et al9 with
minor modifications of our own.10 The results
were expressed as negative or low, moderate, or
high positive, according to the recommenda-
tions of the 1986 workshop on standardisation
of the aCL test.11 The lupus anticoagulant
(LA) activity was detected by coagulation
assays in platelet free plasma obtained by
double centrifugation following the recom-
mendations of the subcommittee on LA of the
Scientific and Standardisation Committee of
the International Society of Thrombosis and
Hemostasis.12
STATISTICAL ANALYSIS
Conventional ÷2 and Fisher’s exact tests were
used for analysing qualitative diVerences, and
Student’s t test for comparison of means in
large independent samples of similar variance.
A p<0.05 value was taken to indicate statistical
significance. When several independent vari-
ables appeared to have statistical significance in
the univariate analysis, a logistic regression test
was performed for multivariate analysis to rule
out possible confounding variables. In this
case, only those variables showing statistical
significance in the multivariate analysis were
considered as significant in the results of the
study. The odds ratio (OR) was calculated for
assessing the risk of appearance of each
variable. A lower limit of the 95% confidence
intervals (CI) that exceeded 1.0 was taken to
indicate statistical significance in the case of
positive association and and upper limit lower
than 1.0 in the case of negative association.
Results of the analysis of continuous variables
are indicated as mean (SD). This statistical
analysis was performed by means of the
SPSS/PC 4.0 and EPISTAT programs using
the information stored in the database pro-
gram.
Results
PATIENTS
Thirty one (91%) patients from the childhood
onset group were female and three male (9%)
(ratio female/male, 10/1, with no diVerence
compared with the adult onset group). Mean
age of this group at disease onset was 11 years
(range 5–14) compared with 32 years (15–48)
for the remaining patients. Mean age at
diagnosis of SLE of childhood onset patients
was 14 years (range 6–28) compared with 34
years (15–85) for the adult onset patients. The
interval between the time of onset and diagno-
sis was three years in the childhood onset group
Table 1 Clinical manifestations at the onset of SLE in the childhood onset patients
compared with the adult onset patients
Manifestations
Childhood onset
(n=34)
Adult onset
(n=396)
p Valueno (%) no (%)
Malar rash 15 (44) 139 (35) NS
Discoid lesions 0 (0) 13 (3) NS
Subacute cutaneous lesions 0 (0) 14 (3) NS
Photosensitivity 8 (23) 80 (20) NS
Oral ulcers 3 (9) 51 (13) NS
Arthritis 22 (65) 247 (62) NS
Serositis 4 (12) 51 (13) NS
Nephropathy 7 (20) 35 (9) 0.04
Neurological involvement 0 (0) 26 (6) NS
Thrombocytopenia 4 (12) 35 (9) NS
Haemolytic anaemia 3 (9) 11 (3) NS
Fever 14 (41) 83 (21) 0.006
Raynaud’s phenomenon 4 (12) 62 (16) NS
Livedo reticularis 1 (3) 2 (0.5) NS
Thrombosis 0 (0) 3 (1) NS
Myositis 1 (3) 15 (4) NS
Lung involvement 0 (0) 5 (1) NS
Chorea 1 (3) 0 (0) NS
Sicca syndrome 0 (0) 2 (0.5) NS
Lymphadenopathy 2 (6) 2 (0.5) 0.03
Table 2 Clinical manifestations during the evolution of SLE in the childhood onset
patients compared with the adult onset patients
Manifestations
Childhood onset
(n=34)
Adult onset
(n=396)
p Valueno (%) no (%)
Malar rash 27 (79) 203 (51) 0.002
Discoid lesions 5 (15) 17 (4) NS
Subacute cutaneous lesions 1 (3) 25 (6) NS
Photosensitivity 15 (44) 140 (35) NS
Oral ulcers 13 (38) 100 (25) NS
Arthritis 30 (88) 320 (81) NS
Serositis 11 (32) 109 (27) NS
Nephropathy 17 (50) 136 (34) NS
Neurological involvement 9 (26) 63 (16) NS
Thrombocytopenia 9 (26) 91 (23) NS
Haemolytic anaemia 5 (15) 26 (6) NS
Fever 21 (62) 170 (43) NS
Raynaud’s phenomenon 7 (20) 100 (25) NS
Livedo reticularis 2 (6) 5 (1) NS
Thrombosis 0 (0) 31 (8) NS
Myositis 1 (3) 28 (7) NS
Lung involvement 2 (6) 15 (4) NS
Chorea 3 (9) 0 (0) <0.001
Sicca syndrome 3 (9) 61 (15) NS
Lymphadenopathy 2 (6) 3 (1) NS
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compared with two years in the adult onset
group (diVerence not significant). Mean time
of evolution of the disease in the childhood
onset group was 85 months (range 1–264) and
in the adult onset group was 73 months
(1–528) (diVerence not significant).
CLINICAL MANIFESTATIONS
Table 1 shows the presenting clinical manifes-
tations for patients with disease onset before or
after age 14. The childhood onset patients
more often had nephropathy (20% v 9% in
adult onset SLE, p=0.04; OR:2.7; 95%CI:1.1,
7), fever (41% v 21%, p=0.006; OR:2.6,
95%CI:1.2, 5.7), and lymphadenopathy (6% v
0.5%, p=0.03, OR: 12.3, 95%CI: 1.2, 127.6).
During the evolution of the disease (table 2),
the childhood onset patients more often
presented malar rash (79% v 51%, p=0.002;
OR:3.7; 95%CI:1.5, 9.5) and chorea (9% v
0%, p<0.001). The frequency of other clinical
features, including serositis, central nervous
system manifestations and pulmonary disease,
did not diVer significantly between the groups.
IMMUNOLOGICAL FEATURES
Table 3 gives the main immunological findings
of childhood onset patients. This group more
frequently exhibited a positive level of anticar-
diolipin antibodies (aCL) of the IgG isotype
when compared with the remaining patients
(29% v 13%, p=0.017; OR:2.9, 95%CI:1.2,
6.8). No significant diVerences were found
among the other antibodies between the two
groups.
TREATMENT AND SIDE EFFECTS
Table 4 summarises the main SLE treatments
prescribed during the study period. Childhood
onset patients more often received azathioprine
when compared with the remaining patients
(15% v 6%, p=0.00004; OR:11.2; 95%CI:2.8,
44.9). No diVerences were detected between
the groups concerning side eVects or drug tox-
icity (table 5).
Discussion
There have been several studies dealing with
childhood onset SLE and their results sug-
gested that age at onset modifies the expression
of the disease in terms of clinical presentation,
pattern of organ involvement, and serological
findings.2–6 13–33 However, the true prevalence of
childhood onset SLE among the SLE popula-
tion is unknown. One of the reasons is that
there is not strict definition of childhood onset
SLE.The most often used cut oV ages are 14 or
16 years at onset of disease14–18 or at
diagnosis.19 20 However several studies use a
higher or lower cut oV age. In our series, 34
(8%) of 430 patients with SLE developed the
initial manifestations clearly attributable to the
disease before the age of 14. In other series, the
prevalence of childhood SLE in children
younger than 16 is nearly 15%.14 15
The onset of SLE is rare before the age of 5
years.13 In our series, one patient presented
clinical manifestations of SLE at the age of 5
years but none of our patients presented these
manifestations before this age.
The female to male ratio in adult onset SLE
is generally found to be slightly more than 10:1.
A higher proportion of men is often reported in
childhood onset SLE in some series.14 20 21 26 27
but not in others.18 22 28 In our series, men rep-
resented 9% of the cases of childhood onset
SLE with a female to male ratio similar to that
in the adult onset SLE.
Although there are many previous publica-
tions of paediatric SLE, the strength of this
study is that, unlike many others, it compares
children and adults from the same clinic popu-
lation. Comparison of the clinical features at
onset between childhood onset and adult onset
patients reveals both similarities and important
diVerences. The frequency of skin, joint,
serositis, and haematological disease was simi-
lar in both groups and correlates with previous
reports.20 However, childhood onset SLE
patients had more frequently renal involve-
ment, fever, and lymphadenopathy, as has also
been reported by other authors.21
Nephropathy is often described in childhood
onset SLE,22–24 26 27 32 although this manifesta-
tion has been more frequently described in
North American series—especially in children
with a Central and South American Hispanic
background33—than in European patients.1 In
our cohort, which includes all the patients
diagnosed as having SLE in our areas, 20%
of childhood onset SLE patients presented
Table 3 Immunological findings at diagnosis of SLE in the childhood onset patients
compared with the adult onset patients
Variable
Childhood onset
(n=34)
Adult onset
(n=396)
p Valueno (%) no (%)
Antinuclear antibodies 33 (97) 388 (97) NS
High anti-dsDNA 29 (85) 360 (90) NS
Anti-Ro (SSA) 5 (14) 82 (20) NS
Anti-La (SSB) 2 (5) 26 (6) NS
Anti-U1-snRNP 4 (11) 50 (12) NS
Anti-Sm 4 (11) 49 (12) NS
Rheumatoid factor 2 (5) 51 (12) NS
IgG anticardiolipin antibodies 10 (29) 50 (13) 0.017
IgM anticardiolipin antibodies 6 (18) 34 (9) NS
Lupus anticoagulant 6 (18) 57 (14) NS
Table 4 Treatments prescribed for SLE during the study
Treatments
Childhood onset
(n=34)
Adult onset
(n=396)
p Valueno (%) no (%)
NSAID 30 (88) 321 (81) NS
Antimalarials 29 (85) 323 (82) NS
Oral corticosteroids 32 (94) 332 (84) NS
Pulse corticosteroids 1 (3) 3 (1) NS
Oral cyclophosphamide 3 (9) 17 (4) NS
Azathioprine 5 (15) 6 (2) 0.00004
Haemodyalisis 0 (0) 1 (0) NS
Antiaggregants 2 (6) 9 (2) NS
Anticoagulants 0 (0) 16 (4) NS
NSAID: Non-steroidal anti-inflammatory drugs.
Table 5 Main side eVects because of the treatments prescribed for SLE during the study
Side eVects
Childhood onset
(n=34)
Adult onset
(n=396)
p Valueno (%) no (%)
Infections 6 (18) 39 (10) NS
Osteoporosis 2 (6) 7 (2) NS
Avascular necrosis 1 (3) 12 (3) NS
Retinopathy 0 (0) 2 (0) NS
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nephropathy as initial clinical manifestation.
Severity in this disease is closely related to renal
involvement.6 26 33 Thus, SLE pattern is gener-
ally more severe in children than in adults. This
inverse correlation between the severity of the
disease and the age of diagnosis has been noted
since the earlier series.25 However, a striking
finding is the additional organ system involve-
ment over the course of follow up in both
adults and children. As time goes on, preva-
lence of renal involvement is similar in both
groups of age. The main significant diVerences
during the evolution of the disease are the more
common prevalence of malar rash and chorea
in the childhood onset group, correlating with
previous reports.15 It is of note that the
treatment given to children was similar to that
given to adults, except for a more common use
of azathioprine in childhood onset patients. No
diVerences were detected between the groups
concerning side eVects or drug toxicity.
Comparison of the autoantibody profiles of
adults and childhood cases shows a similar fre-
quency of increased anti-dsDNA and positive
ANA in both groups. These data are in contrast
with previous reports14 31 in which the fre-
quency of these antibodies is higher in
childhood than adult cases. The only signifi-
cant diVerence between the two groups is the
higher presence of IgG aCL in children than in
adult patients. However, there was not any case
of thrombosis in childhood onset during the
follow up period.
We conclude that the presentation and the
clinical course of SLE varied in our series of
430 patients depending on their age at disease
onset. Nephropathy, fever, and lymphadeno-
pathy were more common in childhood onset
patients as presenting clinical manifestations,
while malar rash, chorea, and detection of IgG
aCL were more common during the evolution
of the disease.
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